1-4 of 4
J. C. Byrd
Close
Sort by
Journal Articles

A Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR) in Combination with High-Dose Cytarabine (HiDAC) in Relapsed or Refractory Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamic (PD) and Clinical Results.

Rebecca B. Klisovic, W. Blum, X. Wei, S. Liu, C. Kefauver, L. Huynh, J. A. Zwiebel, J. C. Byrd, M. R. Grever, G. Marcucci
Journal: Blood
Blood (2005) 106 (11): 2790.
https://doi.org/10.1182/blood.V106.11.2790.2790
Published: 2005
Journal Articles

Methylation of the Tumor Suppressor Gene PTPRO (Receptor-Type Protein Tyrosine Phosphatase) Is Associated with Expression of Important Apoptosis-Related Proteins in Chronic Lymphocytic Leukemia (CLL).

T. Motiwala, K. Ghoshal, PhD, S. Majumder, H. Kutay, D. S. Neuberg, PhD, S. Kitada, PhD, J. C. Reed, MD, PhD, G. W. Dewald, PhD, I. W. Flinn, MD PhD, M. A. Tallman, MD, T. Liu, C. Plass, PhD, D. M. Lucas, PhD, J. C. Byrd, MD, S. T. Jacob, PhD, M. R. Grever, MD
Journal: Blood
Blood (2004) 104 (11): 2804.
https://doi.org/10.1182/blood.V104.11.2804.2804
Published: 2004
Journal Articles

Intracellular Levels of Oblimersen Sodium and Target Downregulation Correlates to Clinical Activity of bcl-2 Antisense in Acute Myeoid Leukemia (AML).

Guido Marcucci, W. Stock, G. Dai, S. Liu, R. Klisovic, M. I. Klisovic, D. Sher, L. Huynh, S. Frankel, W. Blum, R. A. Larson, M. R. Grever, J. C. Byrd, K. K. Chan
Journal: Blood
Blood (2004) 104 (11): 1170.
https://doi.org/10.1182/blood.V104.11.1170.1170
Published: 2004
Journal Articles

International Standardized Approach to Molecular and Flow Cytometric Residual Disease Monitoring in CLL.

A. C. Rawstron, N. Villamor, J. L. Zehnder, P. Ghia, M. Ritgen, S. Bottcher, G. Lozanski, A. P. Mone, D. Colomer, C. Moreno, M. Geuna, P. A. Evans, M. Kneba, Y. Natkunam, S. E. Coutre, F. Caligaris-Cappio, M. J. Hallek, J. C. Byrd, E. Montserrat, P. Hillmen
Journal: Blood
Blood (2004) 104 (11): 15.
https://doi.org/10.1182/blood.V104.11.15.15
Published: 2004